4//SEC Filing
Bernales Sebastian 4
Accession 0000950170-24-015269
CIK 0001785279other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:29 PM ET
Size
20.8 KB
Accession
0000950170-24-015269
Insider Transaction Report
Form 4
Bernales Sebastian
Director
Transactions
- Conversion
Common Stockc
2024-02-13+513,004→ 769,845 total - Conversion
Common Stock
2024-02-13+1,896,445→ 1,896,445 total(indirect: By Humboldt Fund I, LP) - Conversion
Series A-2 Preferred Stock
2024-02-13−353,005→ 0 total→ Common Stock (202,074 underlying) - Conversion
Series A-3 Preferred Stock
2024-02-13−119,699→ 0 total→ Common Stock (68,520 underlying) - Conversion
Series A-4 Preferred Stock
2024-02-13−423,469→ 0 total→ Common Stock (242,410 underlying) - Conversion
Series A-4 Preferred Stock
2024-02-13−2,062,387→ 0 total(indirect: By Humboldt Fund I, LP)→ Common Stock (1,180,592 underlying) - Conversion
Series B Preferred Stock
2024-02-13−1,143,905→ 0 total(indirect: By Humboldt Fund I, LP)→ Common Stock (654,816 underlying) - Conversion
Series B-1 Preferred Stock
2024-02-13−106,627→ 0 total(indirect: By Humboldt Fund I, LP)→ Common Stock (61,037 underlying)
Holdings
- 402,496(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Upon closing of the Issuer's initial public offering, each share of Series A-2 Preferred Stock, Series A-3 Preferred Stock, Series A-4 Preferred Stock, Series B Preferred Stock, and Series B-1 Preferred Stock (collectively, the "Preferred Stock") automatically converted on a one-for-one basis into shares of the Issuer's Common Stock (on an adjusted basis, after giving effect to the reverse stock split of the Common Stock at a ratio of 1 to 1.74692 effected by the Issuer on January 26, 2024). The Preferred Stock had no expiration date.
- [F2]Represents securities held directly by Humboldt Fund I, LP. Humboldt Fund I, LP is solely managed by Humboldt Capital, LLC, which is in turn managed by Sebastian Bernales, Francisco Dopazo and Benjamin Quiroga. Each of Mr. Bernales, Dopazo and Quiroga expressly disclaims beneficial ownership of the securities held by Humboldt Fund I, LP, except to the extent of his pecuniary interest in such securities.
- [F3]Represents securities held directly by Praxis Biotech LLC. The Reporting Person disclaims Section 16 beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of any of the reported securities for purposes of Section 16 or any other purpose.
Documents
Issuer
Metagenomi, Inc.
CIK 0001785279
Entity typeother
Related Parties
1- filerCIK 0001995659
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:29 PM ET
- Size
- 20.8 KB